explore
Previous article:
The cancer drug shortage isn’t new — and neither are the solutions
Next article: Readout Newsletter: Amgen, Regeneron, BGI Group and more
Next article: Readout Newsletter: Amgen, Regeneron, BGI Group and more
explore
focus
-
Unmasking the 'centricity' illusion in clinical trials
2025-09-27 09:31 -
Vyjuvek, a gene therapy for skin wounds, restored vision in one boy
2025-09-27 09:24 -
A protest over insulin prices is seen as a fight for life
2025-09-27 09:05 -
Updated Covid vaccine has 54% effectiveness, new study suggests
2025-09-27 08:33 -
Asahi Kasei to buy Calliditas, picking up kidney disease drug
2025-09-27 07:36 -
Updated Covid vaccine has 54% effectiveness, new study suggests
2025-09-27 07:14